MiNK Therapeutics, Inc.
INKT· Nasdaq
INKTMiNK Therapeutics, Inc.
Filed Nov 3, 2022 · 10-Q · 34 days after period end · 0000950170-22-021565
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Net Income | -$6.33M | -$14.27M | -$6.04M |
| EPS Diluted | -$0.19 | -$0.59 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MiNK Therapeutics, Inc. · CIK 1840229 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 3, 2022 · 34 d after period end
